|
Market Closed -
Oslo Bors
17:45:00 09/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.7000 NOK | +40.56% |
|
-.--% | -49.28% |
| 09-03 | EXACT Therapeutics AS Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-30 | Exact Therapeutics to Delist from Euronext Growth Oslo in October | MT |
| Market Cap | 44.28M 4.81M 4.31M 3.82M 3.59M 6.66M 456M 6.84M 47.23M 18.98M 240M 18.04M 17.65M 731M | P/E 2024 |
-2.49x | P/E 2025 | -1x |
|---|---|---|---|---|---|
| Enterprise Value | 20.37M 2.21M 1.98M 1.76M 1.65M 3.07M 210M 3.15M 21.73M 8.73M 110M 8.3M 8.12M 336M | EV / Sales 2024 |
-
| EV / Sales 2025 | 1,074,437,000x |
| Free-Float |
28.08% | Yield 2024 * |
-
| Yield 2025 | - |
Oslo BorsNOK
| Markets | Quality | ||
|---|---|---|---|
Oslo Bors
| EXTX | Real-time | |
Deutsche Boerse AG
| 56F | Delayed |
| 1 day | +40.56% | ||
| 1 month | -1.41% | ||
| 6 months | -51.39% | ||
| Current year | -49.28% |
| 1 month | 0.43 |  | 0.9 |
| Current year | 0.43 | | 2.7 |
| 1 year | 0.43 | | 2.7 |
| 3 years | 0.43 | | 12.5 |
| 5 years | 0.43 | | 21 |
| 10 years | 0.43 | | 53.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Per Walday
CEO | Chief Executive Officer | 66 | 06/06/2022 |
Svein Kvåle
COO | Chief Operating Officer | - | 01/01/2012 |
John Edminson
DFI | Director of Finance/CFO | - | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | 22/06/2018 | |
Anders Wold
CHM | Chairman | - | 08/06/2022 |
| Director/Board Member | 59 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/4/23 A | Buy | Chairman | 2,500 | 0.0083% | ||
| 1/4/23 A | Buy | Founder | 2,500 | 0.0083% | ||
| 1/4/23 A | Buy | Chief Financial Officer | 2,500 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +40.56% | -.--% | -55.41% | -94.49% | 4.7M | |
| -0.62% | -1.87% | +42.87% | +64.15% | 63.77B | |
| +0.35% | +3.20% | +14.40% | +81.76% | 56.37B | |
| +0.53% | +1.96% | +16.24% | +103.35% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +47.83% | 44.06B | |
| -0.33% | -1.93% | +19.28% | +98.80% | 42.11B | |
| +0.55% | +2.31% | +225.14% | +866.21% | 41B | |
| +3.27% | +47.96% | +112.84% | +96.58% | 34.92B | |
| +1.22% | -1.44% | +14.57% | +46.95% | 32.82B | |
| +0.89% | +20.55% | -40.62% | +349.24% | 24.7B | |
| Average | +4.36% | +7.16% | +37.28% | +166.04% | 39.43B | |
| Weighted average by Cap. | +0.18% | +5.44% | +47.99% | +176.67% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 0.06 0.01 0.01 0.01 0 0.01 0.61 0.01 0.06 0.03 0.32 0.02 0.02 0.97 |
| Net income | -52.33M -5.69M -5.09M -4.51M -4.24M -7.88M -539M -8.08M -55.82M -22.43M -284M -21.32M -20.86M -864M | -86.97M -9.45M -8.46M -7.5M -7.05M -13.09M -896M -13.43M -92.76M -37.28M -471M -35.43M -34.67M -1.44B |
| Net Debt | -98.89M -10.75M -9.61M -8.53M -8.01M -14.88M -1.02B -15.27M -105M -42.39M -536M -40.28M -39.42M -1.63B | -23.91M -2.6M -2.32M -2.06M -1.94M -3.6M -246M -3.69M -25.5M -10.25M -130M -9.74M -9.53M -395M |
Employees
11
- Stock Market
- Stocks
- EXTX Stock
Select your edition
All financial news and data tailored to specific country editions
